FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Clinical Trial Patient Recruitment Services Market Overview:

According to FutureWise analysis the market for Clinical Trial Patient Recruitment Services in 2023 is US$ 0.91 billion, and is expected to reach US$ 1.69 billion by 2031 at a CAGR of 8.00%.

The increasing pharmaceutical and medical industries, rising need for clinical studies, and the adoption of decentralised clinical trials are just a few of the factors driving the clinical trial patient recruiting services market forward.

The COVID-19 pandemic, on the other hand, has had an impact on the global market, causing a voluntary halt in clinical trials around the world. Clinical trials have been extensively interrupted by the temporary shutdown, particularly in the patient recruitment industry. Patients' visitation to study locations have been restricted as a result of the lockdown, which has resulted in considerable withdrawals from various clinical trials.

To be competitive and flexible in the field of healthcare expertise, pharmaceutical companies are increasingly relying on R D activities. Outsourcing tasks ranging from basic research to patient enrollment services is becoming extremely popular. One of the most recent trends in the patient recruitment services market is the use of digital communication methods.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Clinical Trial Patient Recruitment Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Clinical Trial Patient Recruitment Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Clinical Trial Patient Recruitment Services Market:

Antidote
Clara Health
Clariness
BBK Worldwide
Worldwide Clinical Trials
Clinical Site Services (CCSi)
IQVIA
PPD Inc
Veristat
Elligo Health Research

(Note: The list of the major players will be updated with the latest market scenario and trends)

Clinical Trial Patient Recruitment Services Market Segmentation:

By Service Type

Patient Recruitment and Registry Services
Patient Retention Services
Others

By Phase

Phase I
Phase II
Phase III
Phase IV

By Therapeutic Areas

Respiratory Diseases
Pain and Anesthesia
Oncology
Central Nervous System
Cardiovascular
Endocrine
Anti-Infective
Others

By Age Group

Child (Birth-17 Years)
Adult (18 - 64 Years)
Older Adults (65 Years+)

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Clinical Trial Patient Recruitment Services Market By Service Type, By Phase, By Therapeutic Areas, By Age Group and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Clinical Trial Patient Recruitment Services Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Clinical Trial Patient Recruitment Services Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Clinical Trial Patient Recruitment Services Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Clinical Trial Patient Recruitment Services Market, By Service Type Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Patient Recruitment and Registry Services
  2. Patient Retention Services
  3. Others
8. Clinical Trial Patient Recruitment Services Market, By Phase Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
9. Clinical Trial Patient Recruitment Services Market, By Therapeutic Areas Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Respiratory Diseases
  2. Pain and Anesthesia
  3. Oncology
  4. Central Nervous System
  5. Cardiovascular
  6. Endocrine
  7. Anti-Infective
  8. Others
10. Clinical Trial Patient Recruitment Services Market, By Age Group Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Child (Birth-17 Years)
  2. Adult (18 - 64 Years)
  3. Older Adults (65 Years+)
11. North America Clinical Trial Patient Recruitment Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
12. Latin America Clinical Trial Patient Recruitment Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
13. Europe Clinical Trial Patient Recruitment Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
14. Asia Pacific Clinical Trial Patient Recruitment Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
15. Middle East and Africa Clinical Trial Patient Recruitment Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
16. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. Antidote
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Clara Health
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Clariness
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. BBK Worldwide
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Worldwide Clinical Trials
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Clinical Site Services (CCSi)
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. IQVIA
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. PPD Inc
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Veristat
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Elligo Health Research
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
18. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients